Bumetanide for Alzheimer’s disease

Alzheimer’s disease is the most common form of dementia, affecting up to 70% of all people with dementia.1 In the early stages, symptoms can...

Pharmacists key to respiratory health in extreme weather

The recent dust storms and bushfires in NSW and Queensland serve as a reminder of the escalating effects of climate change, leading to an...

Informing pharmacy practice with valuable research

PSA’s Pharmacists in 2023 vision advocates the implementation of a ‘research culture’ in Australia. Here’s how members can pursue valuable research in their own...

PSA NT/SA Branch’s vaccine advocacy work

The PSA SA/NT Branch is fighting for pharmacists to be able to administer more vaccines. Read more about it here.

Supporting palliative care patients and carers in rural and remote areas

Training carers in symptom management for palliative care patients can help them to achieve their goal to be cared for and die at home,...

From the President: Valuing our most vulnerable

Pharmacists spending more time on the ground in aged care has become an urgent priority. It is often said that a measure of civilisation...